Compounding of Veterinary Drugs for Equine Practitioners

Scott D. Stanley; Krysta Moffitt; Valerie Wiebe

doi:10.1016/j.cveq.2016.12.003

Compounding of Veterinary Drugs for Equine Practitioners

Scott D. Stanley
, Krysta Moffitt
, Valerie Wiebe

Veterinary Science

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

Original language	English
Pages (from-to)	213-225
Number of pages	13
Journal	Veterinary Clinics of North America - Equine Practice
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.cveq.2016.12.003
State	Published - Apr 1 2017

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

Keywords

Compounding
Drugs
Extralabel drug use
Horses

ASJC Scopus subject areas

Equine

Access to Document

10.1016/j.cveq.2016.12.003

Cite this

@article{d4d40bbbb07e47fba3e8db38239bb4c6,

title = "Compounding of Veterinary Drugs for Equine Practitioners",

abstract = "Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.",

keywords = "Compounding, Drugs, Extralabel drug use, Horses",

author = "Stanley, \{Scott D.\} and Krysta Moffitt and Valerie Wiebe",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.cveq.2016.12.003",

language = "English",

volume = "33",

pages = "213--225",

number = "1",

}

TY - JOUR

T1 - Compounding of Veterinary Drugs for Equine Practitioners

AU - Stanley, Scott D.

AU - Moffitt, Krysta

AU - Wiebe, Valerie

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

AB - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

KW - Compounding

KW - Drugs

KW - Extralabel drug use

KW - Horses

UR - https://www.scopus.com/pages/publications/85015651067

UR - https://www.scopus.com/pages/publications/85015651067#tab=citedBy

U2 - 10.1016/j.cveq.2016.12.003

DO - 10.1016/j.cveq.2016.12.003

M3 - Review article

C2 - 28325180

AN - SCOPUS:85015651067

SN - 0749-0739

VL - 33

SP - 213

EP - 225

JO - Veterinary Clinics of North America - Equine Practice

JF - Veterinary Clinics of North America - Equine Practice

IS - 1

ER -

Compounding of Veterinary Drugs for Equine Practitioners

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this